{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:58:49Z","timestamp":1782763129227,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":6416,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.fertnstert.2004.03.061","type":"journal-article","created":{"date-parts":[[2004,11,9]],"date-time":"2004-11-09T11:54:11Z","timestamp":1100001251000},"page":"1323-1329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":250,"title":["Serum antim\u00fcllerian hormone\/m\u00fcllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol"],"prefix":"10.1016","volume":"82","author":[{"given":"Andr\u00e9","family":"Hazout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aussage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Junca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cohen-Bacrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2004.03.061_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0015-0282(02)04562-4","article-title":"Age is a better predictor of pregnancy potential than basal FSH levels in women undergoing IVF","volume":"79","author":"Chuang","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib2","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1016\/S0021-9258(18)37375-7","article-title":"Proteolytic processing of M\u00fcllerian inhibiting substance produces a transforming growth factor \u03b2 like fragment","volume":"263","author":"Pepinski","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1210\/jcem-70-1-23","article-title":"An enzyme linked immunoassay for anti m\u00fcllerian hormone: a new tool for the evaluation of testicular function in infants and children","volume":"70","author":"Josso","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib4","first-page":"571","article-title":"M\u00fcllerian inhibiting substance in humans: normal levels from infancy to adulthood","volume":"81","author":"Lee","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib5","first-page":"540","article-title":"Detection of minimal levels of serum anti-mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay","volume":"85","author":"Long","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1095\/biolreprod52.2.444","article-title":"Ontogeny of reproductive abnormalities induced by deregulation of anti-mullerian of hormone expression in transgenic mice","volume":"52","author":"Lyet","year":"1995","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib7","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Antim\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Antim\u00fcllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1043-2760(02)00709-9","article-title":"Jost's hormone inhibitrice comes of age","volume":"13","author":"Josso","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1210\/endo.137.1.8536608","article-title":"Developmental expression of a candidate M\u00fcllerian inhibiting substance type II receptor","volume":"137","author":"Teixeira","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem-70-1-16","article-title":"An immunoassay to detect human M\u00fcllerian inhibiting substance in males and females during normal development","volume":"70","author":"Hudson","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1210\/endo-114-4-1315","article-title":"Production of anti M\u00fcllerian hormone: another homology between Sertoli and granulosa cells","volume":"114","author":"Vigier","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18;","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib15","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/humrep\/15.11.2341","article-title":"Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome","volume":"15","author":"Creus","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib16","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-mullerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"Van Rooij","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Anti M\u00fcllerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"De Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib18","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/humrep\/deg473","article-title":"Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti M\u00fcllerian hormone, inhibin B and ovarian ultrasound","volume":"18","author":"Bath","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.03.061_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0015-0282(99)00639-1","article-title":"Serum mullerian-inhibiting substance levels during normal menstrual cycles","volume":"73","author":"Cook","year":"2000","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028204022319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028204022319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:03:24Z","timestamp":1758006204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028204022319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0015028204022319"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.03.061","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum antim\u00fcllerian hormone\/m\u00fcllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.03.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}